SKP2 and urogenital neoplasm: Therefore, there is an unmet need to develop a hSKP2-KI mouse model for further understanding the oncogenic functions of SKP2 in prostate carcinogenesis and to provide a novel tool for developing novel SKP2 inhibitors.